|
FY2025
12 months to Jun 30, 2025
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
FY2021
12 months to Jun 30, 2021
|
FY2020
12 months to Jun 30, 2020
|
|
|---|---|---|---|---|---|
| Revenues - related party | |||||
| Revenues | |||||
| Revenues | |||||
| Total revenues | |||||
| Cost of revenues | |||||
| Gross profit | |||||
| Selling, general and administrative | |||||
| Research and development | |||||
| Loss on impairment of goodwill | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Interest expense | |||||
| Interest income | |||||
| Other income (expense) | |||||
| Gain on expiration of accrued tax liability | |||||
| Other (expense) income, net | |||||
| Gain (loss) on foreign exchange | |||||
| Total other (expense) income, net | |||||
| Loss before taxes | |||||
| Income taxes | |||||
| Net loss | |||||
| Foreign currency translation | |||||
| Comprehensive loss | |||||
| Net loss attributable to noncontrolling interests | |||||
| Net loss attributable to Dalrada Financial Corporation stockholders | |||||
| Net loss per common share to Dalrada stockholders - basic | |||||
| Net loss per common share to Dalrada stockholders - diluted | |||||
| Weighted average common shares outstanding — basic | |||||
| Weighted average common shares outstanding — diluted | |||||
Loading...